Used in pharmaceutical research as a core scaffold for developing kinase inhibitors, particularly in oncology. Its structure mimics purine bases, allowing it to interact with ATP-binding sites in enzymes involved in cell signaling. Commonly explored in the design of targeted therapies for cancer, including treatments for leukemia and solid tumors. Also investigated for anti-inflammatory and neuroprotective applications due to its ability to modulate key cellular pathways.